Our clients have been busy this year! From completing mergers to raising funding rounds to launching industry-first offerings, we’re amazed by the work our clients are doing and are proud to play a role in their success.
Help us in congratulating some of our clients!
Citeline and Norstella complete merger to form a $5 billion global pharmaceutical technology company
With this most recent merger, Norstella is now one of the world’s largest pharma intelligence solutions providers.
“As the industry moves toward highly targeted therapies focused on smaller patient populations, our clients need solutions that provide actionable answers to critical business questions to help bring drugs to market quicker—ultimately helping patients receive treatment sooner,” said Mike Gallup, CEO of Norstella.
Fathom secures $46M Series B financing
Fathom experienced soaring demand for its medical coding AI in the wake of the pandemic. The company plans to use its funding to continue to scale its engineering team with aims to increase automation rates, broaden specialty support, and meet explosive demand.
“Widespread autonomous medical coding is one of the first steps to rebuilding America’s healthcare payments system into something that actually works for providers, payors, and patients,” said Andrew Lockhart, Fathom CEO and cofounder.
Read more about Fathom and Clarity Quest’s successful partnership.
Be The Match BioTherapies and Atara Biotherapeutics announce multi-year partnership extension
Our client, Be The Match BioTherapies, will continue to supply high-quality healthy donor cells for Atara’s allogeneic T cell platform. Be The Match BioTherapies also announced they will now provide cryopreserved cord blood units for commercial and clinical use.
“The breadth of our cord blood unit registry and the depth of information we provide about each CBU aids developers as they source material for clinical trials, commercial use, or non-clinical research (RUO),” said Donna Regan, senior director, customer ready products at NMDP/Be The Match.
Read more about Be The Match BioTherapies and Clarity Quest’s successful partnership.
ENR ranks CRB among top design and construction firms in life sciences, food and beverage facilities
CRB earned the #2 ranking for pharmaceutical manufacturing design, awarded by the industry’s most respected publications. CRB also published the 2022 version of its highly anticipated Horizons: Life Sciences report, which reveals the challenges facing manufacturers and how they can keep pace with this new rate of discovery.
“This leap in our rankings reflects the exceptional work and innovative solutions our teams provide to clients globally,” said CRB president Ryan Schroeder. “It’s an honor to work with some of the world’s leading experts and see their dedication to providing extraordinary client experiences and delivering powerful solutions that help fuel our clients’ success.”
Read more about CRB and Clarity Quest’s successful partnership.
Ellab expands in the US with acquisition of ICQ Consultants
Long-time client ICQ Consultants recently announced its acquisition by Denmark-based Ellab Corporation. After 15 years in business and steady growth, ICQ’s founders are excited for the opportunities ahead.
“Being our first acquisition in the US, we are so excited to welcome ICQ into the Ellab family,” said Tim Paymaster, president and chief commercial officer at Ellab. “With clear synergies in the expanded CQV Services we can offer to our respective clients, we will strengthen our position as a key strategic partner in the biopharma market. When two strong teams with fantastic cultures come together, the whole is clearly greater than the sum of its parts.”
Read more about ICQ and Clarity Quest’s successful partnership.
TruLite Health launches the first comprehensive health equity platform
Clarity Quest partnered with TruLite Health to help them brand and launch Truity™, the industry’s first comprehensive health equity platform. Truity aims to improve health outcomes for diverse populations by facilitating clinical, social, and behavioral interventions at the point of care.
“We are proud to bring the first comprehensive and seamless workflow solution to the market that swiftly moves the needle on health equity,” said Alan Roga, MD, CEO and founder of TruLite Health.
Read more about TruLite and Clarity Quest’s successful partnership.
Xealth wins Oracle Cerner Client Value Award
Xealth was presented with the award at the 2022 Oracle Cerner Health Conference in recognition of their added value to the companies’ integrated offerings and tangible impact to clients.
“Integrating Xealth into the EHR has driven improved activation, engagement and operational efficiency,” said Mike McSherry, CEO and cofounder of Xealth. “We are thrilled for this approach to be recognized by Oracle Cerner.”
Genesis Research to acquire Market Access Transformation, a leading provider of technology-enabled payer research platforms
Our client, Genesis Research, announced plans in May 2022 to acquire MAT for a combined offering that will enable life sciences companies to generate insights and assess commercial viability faster and more comprehensively than ever before.
“The combination of Genesis Research and MAT creates a novel and unparalleled approach to generating payer insights and evidence,” said Frank A. Corvino, CEO of Genesis Research. “This will enable life sciences companies to both identify and answer the right questions faster than ever before, without sacrificing scientific rigor or transparency.”
What will your success story be in 2023?
If you’re ready to write an epic ending to your success story, let’s partner together.
